Upgrade to SI Premium - Free Trial

Amedisys (AMED) Tops Q2 EPS by 3c

July 31, 2019 4:22 PM
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Management Comments

Next Articles